Deep Breathe

Company profile

About Deep Breathe

Deep Breathe is a medical AI company specializing in automated lung ultrasound diagnostics for critical care environments. The company develops the ATLAS (AI Tactical Assessment System) platform, which uses artificial intelligence to automatically detect life-threatening thoracic conditions including pneumothorax, pleural effusions, and trauma injuries in seconds at the point of care. Deep Breathe's technology is designed to work in the most challenging environments—from battlefields to emergency departments to pre-hospital settings—operating fully offline without internet connectivity or cloud dependence. The platform is vendor-agnostic, compatible with any ultrasound hardware, and runs on standard iOS and Android devices. Deep Breathe serves three primary markets: defense (battlefield diagnostics), hospitals (replacing routine post-procedural chest X-rays), and pre-hospital/transport settings. The company's AI models are trained on over 15 million ultrasound frames and backed by 16 peer-reviewed publications. Their technology addresses a critical gap in trauma care, with the capability to detect 70% of preventable battlefield deaths. Deep Breathe's solutions combine portability, clinical validation, and expert-level AI intelligence to scale ultrasound deployment where traditional imaging infrastructure is unavailable or impractical. The company is headquartered in London, Ontario, Canada, and has secured FDA clearance for its diagnostic technology.

Company description · Deep Breathe official website